首页> 外国专利> BIOMATERIAL FOR TREATMENT OF ACUTE AND CHRONIC SKIN WOUNDS

BIOMATERIAL FOR TREATMENT OF ACUTE AND CHRONIC SKIN WOUNDS

机译:用于治疗急性和慢性皮肤伤口的生物材料

摘要

The present invention relates to functionalized biomaterial for skin wound healing, the biomaterial comprising crosslinked hyaluronic acid and hyaluronic acid gel. The crosslinked and gel form hyaluronic acids are preferably mixed in the biomaterial at the v/v ratio of 1:2, and the final glycoprotein content in the biomaterial ir 15-25 µg/ml. The glycoprotein used for fictionalization of the biomaterial has adenosine monophosphate deaminase activity and N-glycans dominating in the purified glycoprotein fractions are oligomannans Man7GlcNAc, Man8GlcNAc, Man9GlcNAc. The in vitro and in vivo data approves the applicability and efficacy of the funcionalized hyaluronic acid based biomaterial in wound healing. The biomaterial can be applied directly to cleaned acute of chronic wounds to promote reepitelization as well as reculater local immune response.
机译:本发明涉及用于皮肤伤口愈合的功能化生物材料,其包含交联透明质酸和透明质酸凝胶的生物材料。 交联和凝胶形式的透明质酸优选以1:2的v / v比在生物材料中混合,并在生物材料IR15-25μg/ ml中的最终糖蛋白含量。 用于虚拟化生物材料的糖蛋白具有腺苷一磷酸胺酶活性和纯化糖蛋白级分中的N-聚糖是少芽植物MAN7GLCNAC,MAN8GLCNAC,MAN9GLCNAC。 体外和体内数据批准了杂种透明质酸的生物材料在伤口愈合中的适用性和功效。 生物材料可直接应用于清洁慢性伤口的急性伤口,以促进重新遗传,以及归零局部免疫应答。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号